At the time of writing, GeneDx Holdings Corp [WGS] stock is trading at $89.61, up 13.23%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WGS shares have gain 14.81% over the last week, with a monthly amount glided 12.53%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $34. Previously, Craig Hallum started tracking the stock with Buy rating on July 10, 2024, and set its price target to $43.
For the past year, the stock price of GeneDx Holdings Corp fluctuated between $2.63 and $89.11. Currently, Wall Street analysts expect the stock to reach $49.67 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $89.61 at the most recent close of the market. An investor can expect a potential drop of -44.57% based on the average WGS price forecast.
Analyzing the WGS fundamentals
According to GeneDx Holdings Corp [NASDAQ:WGS], the company’s sales were 267.23M for trailing twelve months, which represents an 44.22% jump. Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.32%, and Net Profit Margin reading is -0.31%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.4 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 82.19 points at the first support level, and at 74.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.35, and for the 2nd resistance point, it is at 97.08.
Ratios To Look Out For
It is important to note that GeneDx Holdings Corp [NASDAQ:WGS] has a current ratio of 2.41. In addition, the Quick Ratio stands at 2.27 and the Cash Ratio stands at 0.75. Considering the valuation of this stock, the price to sales ratio is 9.16, the price to book ratio is 12.02.
Transactions by insiders
Recent insider trading involved Stueland Katherine, Chief Executive Officer, that happened on Jan 02 ’25 when 18006.0 shares were sold. CHIEF FINANCIAL OFFICER, Feeley Kevin completed a deal on Jan 02 ’25 to sell 1430.0 shares. Meanwhile, Officer Feeley Kevin bought 1430.0 shares on Jan 02 ’25.
